Search - tctmd.com

Displaying 201 - 220 of 335

Sort: Relevancy | Date

Presentation TCT 2018

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Presenter: Philip M. Urban, Robert W. Yeh, C. Michael Gibson

September 22, 2018

Presentation TCT 2018

Latest Thinking on DAPT Duration: Balancing Risk vs Benefit

Presenter: Philip M. Urban, Robert W. Yeh, Tullio Palmerini

September 22, 2018

Presentation TCT 2018

Ultra-Thin Strut DES: A Meaningful Advance?

Presenter: Renu Virmani, Clemens von Birgelen, Sripal Bangalore

September 22, 2018

Presentation TCT 2018

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Presenter: Renu Virmani, Clemens von Birgelen, David E. Kandzari

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

Presentation TCT 2018

Debate: Drug-Coated Balloons Should be the Primary Treatment Strategy for Long-Segment SFA CTOs!

Presenter: Gary M. Ansel, Ehrin J. Armstrong, Carlos I. Mena-Hurtado

September 21, 2018

Presentation TCT 2018

Will Adjunctive Atherectomy Improve the Outcomes of Drug-Coated Balloons in Complex SFA Lesions?

Presenter: Gary M. Ansel, Ehrin J. Armstrong, Mehdi H. Shishehbor

September 21, 2018

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada

October 30, 2017

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Presenter: Subhash Banerjee, Robert A. Lookstein

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Presenter: Subhash Banerjee, Bryan T. Fisher

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller

October 30, 2017

Presentation TCT 2017

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Presenter: Fernando Alfonso, Patrick W. Serruys, Hemal Gada

October 30, 2017

Presentation TCT 2017

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

Presenter: Subhash Banerjee

October 30, 2017

Presentation TCT 2017

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

Presenter: Fernando Alfonso, Patrick W. Serruys, Paul Kurlansky

October 30, 2017

Presentation TCT 2017

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning

October 30, 2017

Presentation TCT 2017

Will Atherectomy Improve the Results of Drug Coated Balloons? Preclinical and Early Clinical Data

Presenter: Lawrence A. Garcia, Mehdi H. Shishehbor

October 30, 2017

Advertisement

Algorithmic Pharmacology Recommendations for the PCI Patient With Atrial Fibrillation

Latest Thinking on DAPT Duration: Balancing Risk vs Benefit

Ultra-Thin Strut DES: A Meaningful Advance?

Can Contemporary DES Be Improved by Altering the Drug, Polymer, Alloy or Construction?

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Debate: Drug-Coated Balloons Should be the Primary Treatment Strategy for Long-Segment SFA CTOs!

Will Adjunctive Atherectomy Improve the Outcomes of Drug-Coated Balloons in Complex SFA Lesions?

Off Script: Focusing on the Future

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Will Atherectomy Improve the Results of Drug Coated Balloons? Preclinical and Early Clinical Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content